
The Pennant Group, Inc.
- Jurisdiction
United States - LEI
5493007H2OYR6BYLDA64 - ISIN
US70805E1091 (PNTG )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
9
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
The Pennant Group, Inc. provides healthcare services in the United States. Read full profile
Fundamentals
- Net revenue
€681.44M - Gross margin
13.5% - EBIT
€37.71M - EBIT margin
5.5% - Net income
€22.88M - Net margin
3.4%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Cheney Kirk Sterling | EVP, GC and Corp Secy |
|
|
|
|
Guerisoli Brent | Chief Executive Officer |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: August 8, 2025 (Q2 2025)